Edward J. Dulac III - 19 Nov 2021 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role: Chief Financial Officer
Signature: /s/ Cindy Tahl, Attorney-in-Fact
Issuer symbol: FATE
Transactions as of: 19 Nov 2021
Net transactions value: $0
Form type: 4
Filing time: 22 Nov 2021, 16:41:03 UTC
Previous filing: 30 Sep 2021
Next filing: 21 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FATE	Common Stock	Award	$0	+59,540	+114%	$0.000000	111,944	19 Nov 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were granted pursuant to a performance-based restricted stock unit award. The units will vest in three approximately equal installments conditioned upon the achievement, on or before December 31, 2026, of up to three specified late-stage clinical and regulatory milestones of the issuer, so long as the reporting person continues to serve as an employee of the issuer through each milestone achievement.

Content

These shares were granted pursuant to a performance-based restricted stock unit award. The units will vest in three approximately equal installments conditioned upon the achievement, on or before December 31, 2026, of up to three specified late-stage clinical and regulatory milestones of the issuer, so long as the reporting person continues to serve as an employee of the issuer through each milestone achievement.